Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment
Alcohol and Alcoholism · 09.05.2023 · 58 (3) · 266-273
DOI: 10.1093/alcalc/agad010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol and Alcoholism, online erschienen am 09.03.2023. Verfasst von Frederike Stöth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Murtenstrasse 26, 3008 Bern, Switzerland. Hauptthemen laut MEDLINE: Alcoholism. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Swiss Foundation for Alcohol Research.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Aims
Phosphatidylethanol (PEth) is used to monitor alcohol consumption in alcohol use disorder (AUD). In this study, we aim to evaluate the elimination time of PEth with regard to the clinically established 200 and 20 ng/ml cutoffs for PEth 16:0/18:1.
Methods
Data from 49 patients undergoing treatment for AUD were evaluated. PEth concentrations were measured at the beginning and repeatedly during the treatment period of up to 12 weeks to monitor the elimination of PEth. We evaluated the time in weeks until the cutoff concentrations of <200 and <20 ng/ml were achieved. The correlation between the initial PEth concentration and the number of days until the PEth concentration had dropped below 200 and 20 ng/ml was assessed by calculating Pearson’s correlation coefficients.
Results
The initial PEth concentrations ranged from <20 to >2500 ng/ml. In 31 patients, the time until the cutoff values were reached could be documented. Even after 6 weeks of abstinence, PEth concentrations above the cutoff of 200 ng/ml could still be detected in two patients. A strong significant positive correlation was found between the initial PEth concentration and the time required to drop below the two cutoffs.
Conclusion
A waiting period of more than 6 weeks after declared abstinence should be granted for individuals with AUD before using only one single PEth concentration to assess the consumption behavior. However, we recommend to always use at least two PEth concentrations for the evaluation of alcohol-drinking behaviors in AUD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Forensic Medicine, Forensic Toxicology and Chemistry, University of Bern, Murtenstrasse 26, 3008 Bern, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Mittelstrasse 43, 3012 Bern, Switzerland.
- Klinik Südhang, Südhang 1, 3038 Kirchlindach, Switzerland.
- University Hospital of Psychiatry, University of Bern, Bolligenstrasse 111, 3000 Bern, Switzerland.
ORCID-Profile: Frederike Stöth
Förderung
- Swiss Foundation for Alcohol Research
Zitieren
APA
Stöth, F., Weinmann, W., Soravia, L. M., & Pfeifer, P. (2023). Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment. Alcohol and Alcoholism, 58(3), 266-273. https://doi.org/10.1093/alcalc/agad010
Vancouver
Stöth F, Weinmann W, Soravia LM, Pfeifer P. Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment. Alcohol and Alcoholism. 2023;58(3):266-273. doi:10.1093/alcalc/agad010
BibTeX
@article{Stth2023,
author = {Stöth, Frederike and Weinmann, Wolfgang and Soravia, Leila Maria and Pfeifer, Philippe},
title = {Evaluation of Phosphatidylethanol Elimination in Alcohol Use Disorder Patients Undergoing Withdrawal Treatment},
journal = {Alcohol and Alcoholism},
year = {2023},
volume = {58},
number = {3},
pages = {266--273},
doi = {10.1093/alcalc/agad010}
}
EUVIMED